Home › Funds › ORBIMED ADVISORS LLC › AVBP

ORBIMED ADVISORS LLC position in AVBP

ARRIVENT BIOPHARMA INC COM · Health Care

ORBIMED ADVISORS LLC reported holding 3,027,328 shares of AVBP (ARRIVENT BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$105.2M, representing 2.11% of its reported portfolio and ranking #10 among its reported holdings. ORBIMED ADVISORS LLC has disclosed AVBP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)3.03M sh
Reported value held$105.17M
Portfolio Weight2.11%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's AVBP position evolved

ORBIMED ADVISORS LLC first disclosed a stake in AVBP in Q1 2024 at 3,027,328 shares (US$54.1M). The position peaked in Q2 2026 at 3,027,328 shares, worth US$105.2M. Across 10 filings, ORBIMED ADVISORS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,027,328 shares valued at US$105.2M.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 3.03M $54.07M New
Q2 2024 3.03M $56.16M Hold
Q3 2024 3.03M $71.14M Hold
Q4 2024 3.03M $80.65M Hold
Q1 2025 3.03M $55.98M Hold
Q2 2025 3.03M $65.90M Hold
Q3 2025 3.03M $55.85M Hold
Q4 2025 3.03M $60.91M Hold
Q1 2026 3.03M $69.84M Hold
Q2 2026 3.03M $105.17M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVBP and 13F data

AVBP (ARRIVENT BIOPHARMA INC COM) is a Health Care company. 60 other funds we track also report a position in AVBP — the largest reported positions include MONTANOVA CAPITAL, LLC (US$156.9M), INFINITUM ASSET MANAGEMENT, LLC (US$154.2M), Hillhouse Capital (HHLR Advisors) (US$136.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVBP

All AVBP fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held AVBP?

ORBIMED ADVISORS LLC has disclosed AVBP holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is ORBIMED ADVISORS LLC's current position in AVBP?

As of Q2 2026, ORBIMED ADVISORS LLC holds 3.03M shares of AVBP (ARRIVENT BIOPHARMA INC COM), valued at $105.17M, representing 2.11% of its reported portfolio and ranking #10.

Has ORBIMED ADVISORS LLC been buying or selling AVBP?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC held unchanged its position in AVBP. The position peaked in Q2 2026 at 3.03M shares.

Which other funds hold AVBP?

Other major institutional holders of AVBP include MONTANOVA CAPITAL, LLC, INFINITUM ASSET MANAGEMENT, LLC, Hillhouse Capital (HHLR Advisors), among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.